Gabbi will launch in 2023, giving women access to risk assessment results and personalised care plans
The trial is estimated to be completed by the end of 2023
Breast cancer is the most diagnosed cancer in the UK and the second most common cause of cancer mortality in women
Countries like Singapore, India and Japan are set to make the most of the femtech boom
Ovarian cancer is the second most common gynaecologic cancer in the US
Currently, there is no standard or routine screening test for thyroid cancer in the general population
Each year about 264,000 cases of women in the US are diagnosed with breast cancer
Ovarian cancer accounts for more deaths than any other cancer of the female reproductive system
The diagnostic tool is able to identify cell changes that cannot always be seen with standard colposcopy
The interval between smear tests can safely be extended, experts say
